Главная › Метастатический рак › Северная Каролина › Durham
Клинические исследования Метастатический рак в городе Durham, NC
33 исследований по теме Метастатический рак ищут участников в центрах в городе Durham и поблизости (в радиусе около 30 миль). Откройте исследование, чтобы узнать критерии участия и контакты исследовательской группы.
Официальный текст исследования (на английском)
Ищете участников для исследования? Разместите его вверху страницы — $99 на 30 дней →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Набор участниковФаза 1/2
- Avenzo Therapeutics Recruiting Site, Chapel Hill · 10 миль отсюда
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Набор участниковФаза 2
- Duke University Medical Center, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набор участниковФаза 1/2
- Duke University, Durham
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Набор участниковФаза 2/3
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 миль отсюда
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Набор участниковФаза 3
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- Duke University Hospital - Vascular Interventional Radiology, Durham
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Набор участниковФаза 2
- Duke Cancer Institute, Durham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Набор участниковФаза 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 миль отсюда
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13 миль отсюда
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Набор участниковФаза 3
- Duke Cancer Institute, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Набор участниковФаза 3
- University of North Carolina Medical Center, Chapel Hill · 10 миль отсюда
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Набор участниковФаза 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · 10 миль отсюда
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Набор участниковФаза 1
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill · 10 миль отсюда
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Набор участниковФаза 1/2
- Duke University, Durham
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Набор участников
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 миль отсюда
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Набор участниковФаза 1
- Duke Cancer Center, Durham
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- Research Site, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Набор участниковФаза 1
- Research Site, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Набор участниковФаза 1
- Duke Cancer Center, Durham
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Набор участниковФаза 1/2
- Duke University Medical Center, Durham
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
Набор участниковНаблюдательное исследование
- University of North Carolina at Chapel Hill, Chapel Hill · 10 миль отсюда
UNC Metastatic Cancer Radiation Therapy Registry
Набор участниковНаблюдательное исследование
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 миль отсюда
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Набор участниковФаза 1/2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 миль отсюда
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Набор участниковФаза 2/3
- Durham VA Medical Center, Durham, NC, Durham
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Набор участниковФаза 2/3
- Duke University Medical Center, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Набор участниковФаза 1/2
- Duke Cancer Center/ DUMC, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Набор участниковФаза 1
- Duke Cancer Institute, Durham
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Набор участниковФаза 3
- Duke University, Durham
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
Набор участниковНаблюдательное исследование
- Durham Veterans Administration Health Care System (DVAHCS), Durham
- Duke University Medical Center, Durham
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Набор участниковФаза 1
- Duke Cancer Center, Durham
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
Набор участниковФаза 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 миль отсюда
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Набор участниковФаза 1
- Duke University Medical Center - Duke Cancer Institute, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набор участниковНаблюдательное исследование
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 миль отсюда
A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
Набор участниковФаза 3
- Duke University - Trent Center, Durham
A Study of NX-1607 in Adults With Advanced Malignancies
Набор участниковФаза 1
- University of North Carolina, Chapel Hill · 10 миль отсюда
Исследования Метастатический рак в других городах
- Houston, TX104 исследований
- New York City, NY93 исследований
- Nashville, TN70 исследований
- Boston, MA63 исследований
- Los Angeles, CA57 исследований
- St. Louis, MO54 исследований
- Arlington, VA53 исследований
- Philadelphia, PA46 исследований
- Chicago, IL45 исследований
- San Antonio, TX44 исследований
- Washington, DC43 исследований
- Dallas, TX42 исследований
Другие исследования в городе Durham
- Рак молочной железы64 исследований
- Рак (все виды)58 исследований
- Немелкоклеточный рак легкого39 исследований
- Множественная миелома37 исследований
- Острый миелоидный лейкоз33 исследований
- Рак простаты32 исследований
- Рак легких32 исследований
- Колоректальный рак28 исследований
- Рак яичников27 исследований
- Хронический лимфоцитарный лейкоз27 исследований
- Сердечная недостаточность26 исследований
- Рак поджелудочной железы24 исследований
Источник: ClinicalTrials.gov, данные получены 6 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.